Clinical Trial Detail

NCT ID NCT02047344
Title Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Golden Biotechnology Corporation
Indications

lung non-small cell carcinoma

Therapies

Antroquinonol

Age Groups: adult

No variant requirements are available.